The standardized development method of the Japanese guidelines for cancer screening

Japanese Journal of Clinical Oncology

Volumn 38, Issue 4, 2008, Pages 288-295

  Hamashima, Chisato ^a   Saito, Hiroshi ^a   Nakayama, Tomio ^b   Nakayama, Takeo ^c   Sobue, Tomotaka ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

Author keywords

Cancer screening; Guideline; Mortality reduction; Opportunistic screening; Population based screening

Indexed keywords

ACCURACY; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; CONSULTATION; HUMAN; INFORMED CONSENT; JAPAN; MASS SCREENING; PRACTICE GUIDELINE; PUBLICATION; RISK MANAGEMENT; STANDARDIZATION; SYSTEMATIC REVIEW;

HUMANS; JAPAN; MASS SCREENING; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC;

EID: 42549087840     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyn016     Document Type: Article

References (23)

1. Hisamichi S. editors. Guidelines for Cancer Screening Programs. Tokyo: Japan Public Health Association 2001 (in Japanese).
2. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd edn. Baltimore: Williams & Wilkins 1996.
3. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulruw CD, Teuysh SM, et al. Current methods of the U.S. Preventive Services Task Force: A review of the process. Am J Prev Med 2001;20(Suppl 3):21-35.
4. Scottish Intercollegiate Guidelines Network. SIGN50: A Guideline Developer's Handbook. Edinburgh: SIGN 2001.
5. National Institute for Clinical Excellence. The Guideline Development Manual. London: NICE 2006.
6. National Institute for Health and Clinical Excellence. Methods for Development of NICE Public Health Guidance. London: NICE 2006.
7. Briss PA, Zarra A, Psappaioanou M, Fielding J, Hopkins DP, Woolf SH, et al. Developing an evidence-based guide to community preventive services-methods. Am J Prev Med 2000;18(Suppl 1):35-43.
8. AGREE Collaboration. Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument. London: St. George's Hospital Medical School 2001.
9. Miles A, Cockburn J, Smith RA, Wardle J. A perspective from countries using organized screening programs. Cancer 2004;101: 1201-13.
10. Shiffman RN, Scekelle P, Overhage JM, Slutsky J, Grimshaw J, Deshpande AM. Standardized reporting of clinical practice guideline: A proposal from the conference on guideline standardization. Am Intern Med 2003;139:493-8.
11. Oxman AD, Schunemann HJ, Fretheim A. Improving the use of research evidence in guideline development: 7. Deciding what evidence to include. Health Res Policy Syst 2006;4:19.
12. Nomura K. editor. Cancer Statistics in Japan 2005. Tokyo: Foundation for Promotion Cancer Research 2006.
13. Murphy MK, Black NA, Lamping DL, Mckee CM, Sanderson CF, Askham J, et al. Consensus development methods, and their use in clinical guideline development. Health Technol Assess 1998;2(3):i-iv, 1-88.
14. National Institute for Clinical Excellence. Preoperative Tests: The Use of Routine Preoperative Tests for Elective Surgery. London: NICE 2003.
15. Grade of Recommendation, Assessment, Development, and Evaluation (GRADE) Working Group. Grading quality of evidence and strength of recommendation. BMJ 2004;328:1490-4.
16. Guyatt G, Baumann M, Pauker S, Halperin J, Maurer J, Owens DK, et al. Addressing resource allocation issues in recommendations from clinical practice guideline panels. Chest 2006;129:182-7.
17. National Institute for Health and Clinical Excellence. A guide for patients and carers: Contributing to a NICE clinical guideline. 2006.
18. Sheridan SL, Harris RP, Woolf SH. Shared decision making about screening and chemoprevention. Am J Prev Med 2004;26(1): 56-66.
19. Briss P, Rimer B, Reilley B, Coates RC, Lee NC, Mullen P, et al. Promoting informed decisions about cancer screening in communities and healthcare systems. Am J Prev Med 2004;26(1):67-80.
20. Grol R, Grimshow J. Evidence-based implementation of evidence-based medicine. Jt Comm J Qual Improv 1999;25:503-13.
21. The European Community. European Guidelines for Quality Assurance in Mammography Screening. Luxembourg: Europe Against Cancer Programme, Office for official Publications of the European Communities 2006.
22. Sarkeala T, Anttila A, Forsman H, Luostarinen T, Saarenmaa I, Hakama M. Process indicators from ten centers in the Finnish breast cancer screening programme from 1991 to 2000. Eur J Cancer 2004;40:2116-25.
23. Blanks RG, Moss SM, Wallis MG. Monitoring and evaluating the UK National Health Services Breast Screening Programme: Evaluating the variation in radiological performance between individual programmes using PPV-referral diagrams. J Med Screen 2001;8:24-8.